ArticleFrontiers in public health2026
Impact of COVID-19 on sputum isolates and hospital outcomes among patients with pneumonia in Sheffield, United Kingdom: a retrospective cohort study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: The COVID-19 pandemic caused by SARS-CoV-2 severely affected healthcare globally. Strong links have been suggested between the pandemic and changes in the epidemiology of organisms responsible for non-COVID-19 pneumonia. In this study, we examined temporal changes in organisms recovered from sputum culture, integrating laboratory data from all submitted sputum specimens with clinical data from a subset of patients diagnosed with community-acquired pneumonia (CAP). Method: A retrospective study was conducted from August 2017 to May 2024 using data derived from samples from healthcare centres in Sheffield including hospitals, general practices, hospices and other palliative care settings. August 2017 to March 2020, April 2020 to September 2022, and October 2022 to May 2024 were defined as before, during, and after COVID-19 periods, respectively. Absolute percentage-point change in the distribution of organisms was performed at genera level. Results: A total of 50,827 culture positive isolate episodes from sputum samples were analysed during the study period, of which 25,085 (45.4%; 783.9 isolate episodes per month), 11,644 (22.9%; 388.1 isolate episodes per month) and 14,098 (27.7%; 704.9 isolate episodes per month) were obtained before, during and after COVID-19, respectively. Overall, the commonest cultured genus were Conclusion: We found substantial differences in the number of isolate episodes identified. This could present important considerations for treatment of patients presenting with CAP during future pandemics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.